Answers are grounded in this paper and cite their sources.
BACKGROUND AND PURPOSE: Re-irradiation remains a medical challenge due to the high toxicity risk. Proton minibeam radiation therapy (pMBRT), which has already demonstrated a remarkable neurotoxicity reduction, could minimize that risk in the central nervous system re-irradiations. The goal of this study was to perform the first evaluation of the anatomical and functional effects of pMBRT rat brain re-irradiations. MATERIAL AND METHODS: Rats' brains were subjected to either a single conventional X-rays irradiation or additionally to a second irradiation with conventional RT or with pMBRT. Behavioral tests were carried out to assess the functional consequences of the different re-irradiation schemes. Histological evaluations were also performed to characterize tissue lesions, inflammation and astrogliosis. RESULTS: Re-irradiations with conventional RT led to a high skin lesion score (4) as compared to the mild lesion score (2) in the pMBRT re-irradiations, transitory altered locomotor and exploration activity, and had an important impact on cognitive functions such as memory abilities contrary to pMBRT re-irradiations. These results agree with the histological evaluations. Conventional RT re-irradiation resulted in necrosis of the fimbria, alveus necrosis, necrosis of CA1 to CA4 and/or gyrus dentatus, vasculopathy in the plexes in 88%, 25 %, 38 % and 50 % of the animals, respectively. The only histological finding in pMBRT re-irradiated animals was necrosis of the fimbria in 50% of the animals. CONCLUSIONS: Re-irradiation with pMBRT results in less neurotoxicity both from anatomical and functional point of view and it could be a safe alternative to current clinical practice.
No takes yet. Share an insight, caveat, or question.
Prezado et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: